Production (Stage)
CareDx, Inc
CDNA
$16.95
-$0.16-0.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.19% | 4.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.19% | 4.46% | |||
| Cost of Revenue | 0.84% | 2.20% | |||
| Gross Profit | -3.65% | 5.59% | |||
| SG&A Expenses | -25.91% | 27.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.94% | 14.03% | |||
| Operating Income | 59.71% | -89.60% | |||
| Income Before Tax | -113.17% | 1,184.64% | |||
| Income Tax Expenses | -66.08% | -14.50% | |||
| Earnings from Continuing Operations | -113.27% | 1,153.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -113.27% | 1,153.05% | |||
| EBIT | 59.71% | -89.60% | |||
| EBITDA | 73.30% | -135.40% | |||
| EPS Basic | -113.03% | 1,126.50% | |||
| Normalized Basic EPS | 72.90% | -141.67% | |||
| EPS Diluted | -114.13% | 1,060.21% | |||
| Normalized Diluted EPS | 70.92% | -125.23% | |||
| Average Basic Shares Outstanding | 1.80% | 2.61% | |||
| Average Diluted Shares Outstanding | -5.08% | 10.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||